Rate expectations just swung again, and this time the move cuts funding pressure for growth and technology stocks that live and die by borrowing costs and future cash flows. When odds of an October Fed hike shrink and inflation readings cool, investors who react slowly risk watching others reposition first. This article walks through three US growth and technology stocks sensitive to interest rates that screens flag as positively exposed to the latest Fed and inflation signals.
The stocks highlighted below are only a starter pack. The full screen surfaced 39 more US growth and technology companies with equally compelling interest rate stories that are not covered here. To identify and analyze your own highest conviction ideas from that broader group, head straight into the US Growth and Technology Stocks Sensitive to Interest Rates screener.
Cellebrite DI (CLBT)
Overview: Cellebrite DI provides software and cloud tools that help governments and enterprises legally collect, analyze, and manage complex digital evidence globally.
Operations: Cellebrite DI reports about US$514 million from internet software and services, with around US$274 million from America and US$240 million from EMEA and APAC combined.
Market Cap: US$2.8b
Cellebrite DI fits this rate sensitive growth-tech theme because it monetizes software and cloud-based digital investigation tools whose value leans heavily on future subscription cash flows rather than today’s earnings, so shifting expectations for funding costs matter.
"The accelerating shift by law enforcement and intelligence agencies toward more advanced digital investigation platforms, driven by surging digitalization, larger data volumes, and increasing crime sophistication, is fueling rapid adoption of Cellebrite's cloud/SaaS solutions and digital forensics platforms (Inseyets, Guardian, Pathfinder)."
What really tests that setup is how one unresolved pressure on future contract size and timing eventually flows through to margins.
That margin question is exactly what the full narrative for Cellebrite DI unpacks in detail, separating short term contract noise from longer term demand momentum.
Viavi Solutions (VIAV)
Overview: Viavi Solutions supplies test, monitoring, and optical technologies that keep high speed communications, data centers, and secure networks running reliably.
Operations: Viavi Solutions generates about US$1.2b from Network and Service Enablement and roughly US$335 million from Optical Security and Performance Products, serving customers across the United States, EMEA, Greater China, and the broader Asia Pacific and Americas regions.
Market Cap: US$11.6b
Viavi Solutions lands in this rate sensitive growth tech screen because its tools sit behind large, long lived network upgrades where customer spending and valuation both react strongly when financing costs or discount rates shift.
"Viavi is experiencing robust and sustained demand across the data center ecosystem, with customers updating optical connectivity to 400G, 800G, and now 1.6T, enabling multi year upgrade cycles and expanding its total addressable market, which should drive structural revenue growth through 2026 and beyond."
What happens to that upgrade cycle if a single unseen pressure on customer budgets starts to pinch pricing power and margin quality.
If that hidden pressure matters for you, read the full narrative for Viavi Solutions to see how Viavi Solutions could still accelerate or stall as rates keep shifting.
Veeco Instruments (VECO)
Overview: Veeco Instruments supplies semiconductor and thin film process equipment that helps manufacturers build advanced chips, photonics devices, and other microelectronics worldwide.
Operations: Veeco Instruments generates about US$683 million from semiconductor and thin film process equipment, with revenue concentrated in Rest of APAC, China, and the United States.
Market Cap: US$3.5b
Veeco Instruments fits this interest rate sensitive growth-tech screen because chipmaking tools are long lived purchases that hinge on multi year capital spending plans, so shifts in funding costs and tech optimism can quickly change how attractive new fabs and advanced packaging projects look.
"Order backlog of $555 million at the end of 2025, up 35% year over year with a skew to second half 2026 shipments, gives Veeco Instruments room for a revenue mix shift toward longer lead, higher complexity programs that could support a richer gross margin profile as that backlog converts."
What happens to that margin story if one rate sensitive assumption in those long dated chip and photonics orders quietly starts to move?
That rate exposed hinge is exactly what the full narrative for Veeco Instruments untangles. It shows where Veeco Instruments’ backlog, capital cycles, and margin potential may be quietly decoupling from headline sentiment.
Seeking Fresh Alternatives Before They Fly
Fresh opportunities can move quickly, and once momentum builds the cleanest entries may not remain available. Review these curated ideas while they are still relatively under the radar.
- Target reliable cash generators with room to compound by scanning a curated list of solid balance sheet and fundamentals (25 results) before broader attention turns to financial strength.
- Seek potential income and resilience as yields remain in focus by reviewing a tight group of 7 dividend fortresses before prices fully reflect those payout characteristics.
- Consider positioning ahead of potential infrastructure-related activity by tracking a focused basket of 40 power grid technology and infrastructure stocks while funding trends and grid upgrades are still being evaluated.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com